Wilfried W H Roeloffzen

6PUBLICATIONS
45CO-AUTHORS
Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 08, 2026
Prioritizing quality of life over thrombotic risk: Thromboprophylaxis in multiple myeloma - an interview study.

|May 12, 2026
Daratumumab-bortezomib-cyclophosphamide-dexamethasone for newly diagnosed amyloidosis: ANDROMEDA final survival analysis.

|Apr 06, 2026
Isatuximab, carfilzomib, lenalidomide and dexamethasone in newly diagnosed multiple myeloma: a randomized phase 3 trial.

Francesca Gay, Wilfried Roeloffzen, Meletios A Dimopoulos

|Nov 27, 2025
Kinetics of Serum-Free Light Chain Removal by High-Cutoff Hemodialysis in Patients with Multiple Myeloma and Acute Renal Failure.

Wilma A Veldman, Debora J Weerman, Saskia Molog

|Feb 14, 2020
A real-life cohort study of immunoglobulin light-chain (AL) amyloidosis patients ineligible for autologous stem cell transplantation due to severe cardiac involvement or advanced disease.

Anne F Brunger, Hans L A Nienhuis, Johan Bijzet

Pageof 1

Frequent Collaborators

2 joint publications

Francesca Gay

2 joint publications

Monique C Minnema

2 joint publications

Niels W C J van de Donk

2 joint publications

Pieter Sonneveld